Skip to contentI
Imunon, Inc.
I
IMNNImunon, Inc. Q4 2022 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$125.00K$125.00Kderived±0.0% vs Q4 2021 Net Income-$13.23M-$13.23MderivedN/M vs Q4 2021 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$6,926,751N/M Operating Cash Flowderived-$5,007,558N/M Free Cash Flowderived-$5,052,467N/M Margins · derivedOperating margin-5541.4%−1148.7 pt vs Q4 2021
Net margin-10586.1%−7209.1 pt vs Q4 2021
ended Dec 31, 2022 · filed Mar 30, 2023 · 89 d after period end